Zymeworks Inc (ZYME-Q) Press Releases

Latest News

FILE - A U.S. Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md., on Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File)

Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval

The Globe and Mail - Thu Nov 21, 2:18PM CST

The Globe and Mail

Thu Nov 21, 2:18PM CST

Jazz Pharmaceuticals says the U.S. Food and Drug Administration has approved use of the tumor-fighting antibody to treat adults with a form of biliary-tract cancer (BTC)

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire - Thu Nov 21, 5:05AM CST

GlobeNewswire

Thu Nov 21, 5:05AM CST

FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)

GlobeNewswire - Thu Nov 21, 5:00AM CST

GlobeNewswire

Thu Nov 21, 5:00AM CST

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

GlobeNewswire - Tue Nov 5, 5:00AM CST

GlobeNewswire

Tue Nov 5, 5:00AM CST

Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire - Thu Oct 31, 3:05PM CDT

GlobeNewswire

Thu Oct 31, 3:05PM CDT

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire - Tue Oct 29, 5:00AM CDT

GlobeNewswire

Tue Oct 29, 5:00AM CDT

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

GlobeNewswire - Fri Oct 25, 5:00AM CDT

GlobeNewswire

Fri Oct 25, 5:00AM CDT

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

GlobeNewswire - Mon Oct 21, 5:00AM CDT

GlobeNewswire

Mon Oct 21, 5:00AM CDT

Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024

GlobeNewswire - Thu Oct 10, 5:30AM CDT

GlobeNewswire

Thu Oct 10, 5:30AM CDT

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

Newswire.ca - Thu Sep 19, 11:08AM CDT

Newswire.ca

Thu Sep 19, 11:08AM CDT

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

Recent Breakthroughs in Cancer Research Could Impact These Key Companies

BayStreet.ca - Thu Sep 19, 10:52AM CDT

BayStreet.ca

Thu Sep 19, 10:52AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – In the oncology world, there’s been plenty to celebrate...

Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)

GlobeNewswire - Tue Sep 3, 3:30PM CDT

GlobeNewswire

Tue Sep 3, 3:30PM CDT

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire - Thu Aug 22, 5:30AM CDT

GlobeNewswire